Compared with ZY0511, GSK2879552 which is Tranylcypromine (TCP)-based LSD1 inhibitor at the concentration of 50 μM had no inhibitory effect on DLBCL cells (data not shown). The gene discussed is KDM1A; the disease is diffuse large B-cell lymphoma.